#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Screening of a neuronal cell model of Tau pathology for therapeutic compounds"
SET DOCUMENT Version     = "1.0.0"
SET DOCUMENT Authors     = "Esther Wollert"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/6ebac4dddc69402cb8fdd90c746ff6ee572c95af/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############

SET STATEMENT_GROUP = "Esther"

# Add statements below this comment

SET Citation = {"PubMed","Neurobiol Aging. 2018 Dec 13;76:24-34. doi: 10.1016/j.neurobiolaging.2018.11.026. [Epub ahead of print]","30640040"}

SET Evidence = "As shown before, Tau aggregation (on the level of
 oligomeric and/or fibril aggregates) is toxic for cells."
a(HBP:"Tau aggregates") -> bp(GO:"cell killing")

SET Evidence = "The dose response screening identified compounds
related to the inhibition of 3 major targets led to inhibition
of Tau aggregation: p38 MAPK (7 out of 8 compounds in the initial
library), VEGFR1/2 (3 of 8) and TGF (3 of 10). "
act(p(HGNC:MAPK14)) -> a(HBP:"Tau aggregates")
act(p(HGNC:FLT1)) -> a(HBP:"Tau aggregates")
act(p(HGNC:KDR)) -> a(HBP:"Tau aggregates")
act(p(FPLX:TGFB)) -> a(HBP:"Tau aggregates")

SET Evidence = " Conversely, compounds related to HDAC inhibition
(16 of 20) led to enhanced Tau aggregation, suggesting that HDAC
activity is important for suppressing aggregation"
act(p(FPLX:HDAC)) -| a(HBP:"Tau aggregates")

SET Evidence = "Treatment with Givinostat (1.2 µM) lead to a
nearly 7-fold increase in the fraction of ThS + cells (from
~ 12% to ~ 84%, Fig. S4A and B, blue lines) compared to the
uninduced control, and 2.5-fold compared to the induced control. "
#Givinostat is a HDAC inhibitors
a(PUBCHEM:"9804992") -| act(p(FPLX:HDAC))
a(PUBCHEM:"9804992") -> a(HBP:"Tau aggregates")

SET Evidence = "The GO terms enrichment for the molecular function
related to the activator targets elicit the following terms ranking
as first ten for p-value: (1) deacetylase activity, (2) hydrolase
activity (acting on carbon-nitrogen but not peptide bond), (3)
hydrolase activity (acting on carbonnitrogen but not peptide bonds
in linear amides), (4) histone deacetylase activity, (5) protein
deacetylase activity, (6) protein kinase binding, (7) transcription
cofactor activity, (8) transcription repressor binding, (9) kinase
binding, (10) protein kinase C binding. For the inhibitor targets
the first ten terms returned where: (1) protein kinase activity,
(2) phosphotransferase activity (alcohol group as acceptor), (3)
protein serine/threonine kinase activity, (4) nucleotide binding,
(5) ribonucleotide binding, (6) transferase activity, (7) transferase
activity (transferring phosphorus-containing groups), (8) purine
nucleotide binding, (9) purine ribonucleotide binding, (10) adenyl
nucleotide binding."
#targets involved in the regulation of the Tau aggregation
#a(GO:"deacetylase activity") pos a(HBP:"Tau aggregates")
#a(GO:"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds") pos a(HBP:"Tau aggregates")
#a(GO:"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides") pos a(HBP:"Tau aggregates")
#a(GO:"histone deacetylase activity") pos a(HBP:"Tau aggregates")
#a(GO:"protein deacetylase activity") pos a(HBP:"Tau aggregates")
#a(GO:"protein kinase binding") pos a(HBP:"Tau aggregates")
#a(GO:"transcription coregulator activity") pos a(HBP:"Tau aggregates")
#a(GO:" DNA-binding transcription repressor activity ") pos a(HBP:"Tau aggregates")
#a(GO:"kinase binding") pos a(HBP:"Tau aggregates")
#a(GO:"protein kinase C binding") pos a(HBP:"Tau aggregates")

#a(GO:"protein kinase activity") neg a(HBP:"Tau aggregates")
#a(GO:"phosphotransferase activity, alcohol group as acceptor") neg a(HBP:"Tau aggregates")
#a(GO:"protein serine/threonine kinase activity") neg a(HBP:"Tau aggregates")
#a(GO:"nucleotide binding") neg a(HBP:"Tau aggregates")
#a(GO:"ribonucleotide binding") neg a(HBP:"Tau aggregates")
#a(GO:"transferase activity") neg a(HBP:"Tau aggregates")
#a(GO:"transferase activity, transferring phosphorus-containing groups") neg a(HBP:"Tau aggregates")
#a(GO:"purine nucleotide binding") neg a(HBP:"Tau aggregates")
#a(GO:"purine ribonucleotide binding") neg a(HBP:"Tau aggregates")
#a(GO:"adenyl nucleotide binding") neg a(HBP:"Tau aggregates")

SET Evidence = "Tab. 1A-B: Summary of the Tau aggregation modulators
 (inhibitors = 18 (A), stimulators = 10 (B)) which show decrease /
 increase in the amount of ThS + cells without affecting the expression
 level of TauRD∆K compared to the compound untreated control. "
#stimulators
a(PUBCHEM:"9865515") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"4261") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"24756910") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"448537") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"5318517") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"71295844") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"42640") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"2746") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"71729974") -> a(HBP:"Tau aggregates")
a(PUBCHEM:"53340666") -> a(HBP:"Tau aggregates")
#inhibitors
a(PUBCHEM:"11154925") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"4521392") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"11234052") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"46209426") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"6321424") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"11570805") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"156422") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"9880") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"3033825") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"5311272") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"49806720") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"9839311") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"447966") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"11655119") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"10435235") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"5833") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"10341154") -| a(HBP:"Tau aggregates")
a(PUBCHEM:"4878") -| a(HBP:"Tau aggregates")
#stimulator target
a(PUBCHEM:"9865515") -- p(FPLX:HDAC)
a(PUBCHEM:"4261") -- p(HGNC:HDAC1)
a(PUBCHEM:"4261") -- p(HGNC:HDAC3)
a(PUBCHEM:"24756910") -- p(FPLX:"HDAC_I")
a(PUBCHEM:"24756910") -- p(FPLX:"HDAC_II")
a(PUBCHEM:"24756910") -- p(HGNC:EGFR)
a(PUBCHEM:"24756910") -- p(HGNC:ERBB2)
a(PUBCHEM:"448537") -- p(FPLX:ESR)
a(PUBCHEM:"5318517") -- p(FPLX:NFkappaB)
a(PUBCHEM:"5318517") -- p(FPLX:Actin)
a(PUBCHEM:"71295844") -- p(HGNC:GSK3A)
a(PUBCHEM:"71295844") -- p(HGNC:GSK3B)
a(PUBCHEM:"42640") -- p(HGNC:MDM4)
a(PUBCHEM:"2746") -- p(FPLX:"HDAC_I")
a(PUBCHEM:"71729974") -- p(HGNCGENEFAMILY:"Lysine demethylases")
a(PUBCHEM:"53340666") -- p(HGNC:HDAC6)
#inhibitor target
a(PUBCHEM:"11154925") -- p(HGNC:KDR)
a(PUBCHEM:"4521392") -- p(HGNC:TGFBR1)
a(PUBCHEM:"11234052") -- p(HGNC:KDR)
a(PUBCHEM:"46209426") -- p(FPLX:ROCK)
a(PUBCHEM:"6321424") -> act(p(HGNCGENEFAMILY:"Chloride channel accessory"))
a(PUBCHEM:"11570805") -- p(HGNC:MAPK14)
a(PUBCHEM:"156422") -- p(HGNC:MAPK14)
a(PUBCHEM:"9880") -| act(p(HGNC:AR))
a(PUBCHEM:"3033825") -- p(HGNC:TNC)
a(PUBCHEM:"5311272") -| act(p(FPLX:"Gamma_secretase"))
a(PUBCHEM:"49806720") -| act(p(HGNC:ALK))
a(PUBCHEM:"9839311") -- p(HGNC:SELE)
a(PUBCHEM:"9839311") -- p(HGNC:ICAM1)
a(PUBCHEM:"447966") -- p(HGNC:TGFBR1)
a(PUBCHEM:"11655119") -- p(HGNC:TGFBR1)
a(PUBCHEM:"11655119") -- p(HGNC:TGFBR2)
a(PUBCHEM:"10435235") -| act(p(FPLX:"Gamma_secretase"))
a(PUBCHEM:"5833") -- p(HGNC:AR)
a(PUBCHEM:"10341154") -- p(HGNC:MAPK14)
a(PUBCHEM:"4878") -- p(HGNC:LCK)
a(PUBCHEM:"4878") -- p(HGNC:FYN)
